Discontinuation report HUMATROPE

Last updated on 2021-01-18 History
Report ID 106800
Drug Identification Number 00745626
Brand name HUMATROPE
Common or Proper name Somatropin for injection
Company Name ELI LILLY CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SOMATROPIN
Strength(s) 1MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS
Packaging size 5 mg vial
ATC code H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-01-15
Actual discontinuation date 2021-01-15
Remaining supply date 2021-01-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions.
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-02-20 English Compare
v2 2020-02-20 French Compare
v3 2020-02-20 English Compare
v4 2020-02-20 French Compare
v5 2020-05-11 English Compare
v6 2020-05-11 French Compare
v7 2021-01-18 English Compare
v8 2021-01-18 French Compare

Showing 1 to 8 of 8